Hideyuki Takizawa | Internal Medicine | Best Researcher Award

Dr. Hideyuki Takizawa | Internal Medicine | Best Researcher Award

The University of Tokyo | Japan

Dr. Hideyuki Takizawa is Chief Medical Officer and Chief Research Officer at Cliffhanger Inc., where he also leads the Division of Clinical Operations and Clinical Research Development (CROs and pharmaceutical companies) in Tokyo. He earned his MD and MSc from the Graduate School of Medicine at The University of Tokyo, followed by a PhD in Internal Medicine, awarded with honours for scientific research excellence and a translational medicine award. His doctoral work spanned clinical laboratory medicine and internal medicine, and focused on the biochemical and clinical mechanisms that link lipid metabolism to metabolic and cardiovascular disease, especially diabetes mellitus. Dr. Takizawa’s research has centred on serum sphingolipids and glycerophospholipids—specifically lipid subclasses such as phosphatidylinositol/lysophosphatidylinositol, phosphatidylglycerol/lysophosphatidylglycerol, and ceramides—and their associations with diabetes and its vascular and metabolic complications. He has applied omics-based lipid profiling to integrate molecular, cellular and clinical observations, thereby advancing translational medicine and precision treatment strategies for metabolic disorders.

Profile: Orcid 

Featured Publications 

Takizawa, H., Uranbileg, B., Yutaka, Y., & Kurano, M. (2025). Serum sphingolipid and glycerophospholipid synthesis, especially phosphatidylinositol/lysophosphatidylinositol, phosphatidylglycerol/lysophosphatidylglycerol, and ceramides, are significantly influenced by diabetes mellitus and associated with its complications. Diabetology, 6(10), Article 112.

Prof Dr. Zhen Yang – Oncology and immunity – Young Scientist Award

Prof Dr. Zhen Yang - Oncology and immunity - Young Scientist Award

Tianjin Union Medical Center of Nankai University - China

Author Profile 

ORCID

Early academic pursuits 🎓

Dr. Zhen Yang embarked on a journey in the medical field with a focus on understanding complex biological systems. With a Doctor of Medicine degree, Zhen cultivated a deep interest in the mechanisms of diseases, particularly malignant tumors. This foundation laid the groundwork for a career dedicated to advancing medical science and improving therapeutic strategies.

Professional endeavors 🏢

Currently, Zhen serves as a postdoctoral research fellow and a distinguished research fellow, overseeing laboratory technicians and guiding research initiatives. Zhen has played a crucial role in leading significant projects, including the National Natural Science Foundation of China and key initiatives from the Tianjin Health and Education Commissions. These positions reflect Zhen's leadership and commitment to fostering innovative research environments.

Contributions and research focus 🔬

Zhen's research primarily centers on immunotherapy for malignant tumors, integrating Chinese and Western medicine approaches. This unique perspective aims to enhance treatment efficacy and patient outcomes. With over ten published papers in prestigious journals, including Oncology and immunity Autophagy, Cancer Letters, and International Journal of Biological Macromolecules, Zhen's work significantly contributes to the scientific understanding of immunotherapeutic strategies and their applications in clinical settings.

Accolades and recognition 🏅

Zhen's contributions to medical research have not gone unnoticed, with recognition from various academic bodies and funding agencies. Leading projects funded by the National Natural Science Foundation of China and receiving support from Tianjin’s health and education sectors Oncology and immunity underscores Zhen's influence and reputation within the scientific community. Zhen’s work has been pivotal in advancing research methodologies and clinical applications in immunotherapy.

Impact and influence 🌍

The impact of Zhen Yang's research extends beyond academic publications, influencing clinical practices and therapeutic strategies for treating malignant tumors. By bridging traditional and modern medicine, Zhen's work fosters a holistic approach to cancer treatment, potentially Oncology and immunity transforming how therapies are designed and implemented. Zhen’s research serves as a valuable resource for other scientists and clinicians in the field.

Legacy and future contributions 🔮

Dr. Zhen Yang's legacy is one of innovation and dedication to improving cancer therapies. As research in immunotherapy continues to evolve, Zhen is poised to make further significant contributions that could redefine treatment paradigms. The integration of traditional and modern practices in Zhen's work promises to open new avenues for research and clinical application, ensuring a lasting impact on future generations of medical professionals and researchers.

Notable Publications